Lumexa Imaging Holdings, Inc.
NASDAQLumexa Imaging Holdings enters the week with a fresh analyst cut pressing down on a stock that has already given back all of its post-Q1 bounce and then some. The standout development this week is the Barclays target reduction. Andrew Mok at Barclays — who had maintained an Overweight rating through the initial Q1-driven selloff — cut his price target this morning from $15 to $9, a…
LMRI cost to borrow surges to 4.27% from 0.85% in one week, a spike of nearly 400%, as short interest declines 33% over the same period.
Snapshot as of 21 May 2026
Lumexa Imaging Holdings enters the week with a fresh analyst cut pressing down on a stock that has already given back all of its post-Q1 bounce and then some. The standout development this week is the Barclays target…
Lumexa Imaging Holdings heads into the week after its Q1 print with short sellers retreating sharply — and a stock that's finally starting to recover from a bruising March. The clearest story this week is the short…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LMRI — free to start on ORTEX.
Sign up for free →Open LMRI on ORTEX